Search Results - "MANNUCCI, Pier Mannuccio"
-
1
Thrombogenicity and cardiovascular effects of ambient air pollution
Published in Blood (01-09-2011)“…Exposure to air pollution is associated with adverse effects on health. In particular, a strong epidemiologic association is observed between acute and chronic…”
Get full text
Journal Article -
2
Pollution from fine particulate matter and atherosclerosis: A narrative review
Published in Environment international (01-05-2023)“…According to the WHO, the entire global population is exposed to air pollution levels higher than recommended for health preservation. Air pollution is a…”
Get full text
Journal Article -
3
How we choose factor VIII to treat hemophilia
Published in Blood (03-05-2012)“…In high-income countries, the large availability of coagulation factors for replacement therapy of patients with hemophilia A has raised the life expectancy of…”
Get full text
Journal Article -
4
Hemophilia therapy: the future has begun
Published in Haematologica (Roma) (01-03-2020)“…The success story of hemophilia care first began in the 1970s, when the availability of plasma-derived concentrates of coagulation factor VIII (FVIII) and…”
Get full text
Journal Article -
5
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study
Published in European journal of clinical pharmacology (01-05-2011)“…Purposes We evaluated the prevalence and factors associated with polypharmacy and investigated the role of polypharmacy as a predictor of length of hospital…”
Get full text
Journal Article -
6
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method
Published in Hepatology (Baltimore, Md.) (01-07-2010)“…Patients with cirrhosis possess an imbalance in procoagulant versus anticoagulant activity due to increased factor VIII and decreased protein C. This imbalance…”
Get full text
Journal Article -
7
Long-Term Evaluation of the Risk of Recurrence After Cerebral Sinus-Venous Thrombosis
Published in Circulation (New York, N.Y.) (29-06-2010)“…The clinical course of cerebral sinus-venous thrombosis (CSVT) is largely unknown because prospective studies with a long follow-up and with the goal to assess…”
Get full text
Journal Article -
8
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests
Published in Hepatology (Baltimore, Md.) (01-03-2005)“…The role played by coagulation defects in the occurrence of bleeding in cirrhosis is still unclear. This is partly due to the lack of tests that truly reflect…”
Get full text
Journal Article -
9
The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation
Published in Hepatology (Baltimore, Md.) (01-08-2007)“…The model for end‐stage‐liver‐disease (MELD) is a mathematical score used to prioritize patients for liver transplantation and includes results for creatinine,…”
Get full text
Journal Article -
10
The Coagulopathy of Chronic Liver Disease
Published in The New England journal of medicine (14-07-2011)“…Conventional wisdom is that chronic liver disease is an acquired bleeding disorder. However, the imbalance between procoagulant and anticoagulant activities…”
Get full text
Journal Article -
11
Living Near Major Traffic Roads and Risk of Deep Vein Thrombosis
Published in Circulation (New York, N.Y.) (23-06-2009)“…Particulate air pollution has been consistently linked to increased risk of arterial cardiovascular disease. Few data on air pollution exposure and risk of…”
Get full text
Journal Article -
12
Prophylactic management of patients with von Willebrand disease
Published in Therapeutic Advances in Hematology (01-12-2021)“…Von Willebrand disease, the most common inherited bleeding disorder that affects both males and females, is due to quantitative or qualitative defects of the…”
Get full text
Book Review Journal Article -
13
Acquired von Willebrand syndrome: focused for hematologists
Published in Haematologica (Roma) (01-08-2020)“…The acquired von Willebrand syndrome (AvWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. However,…”
Get full text
Journal Article -
14
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
Published in Haematologica (Roma) (01-02-2008)“…1 Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, University of Milan, Department of Medicine and Medical Specialities, IRCCS Maggiore Hospital,…”
Get full text
Journal Article -
15
Recombinant FVIII: the milestone of modern hemophilia treatment
Published in Haematologica (Roma) (01-05-2023)Get full text
Journal Article -
16
Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities
Published in Circulation (New York, N.Y.) (03-08-2004)“…One third of cases of upper-extremity deep vein thrombosis (DVT) are primary, ie, they occur in the absence of central venous catheters or cancer. Risk factors…”
Get full text
Journal Article -
17
Novel evidence for a greater burden of ambient air pollution on cardiovascular disease
Published in Haematologica (Roma) (01-12-2019)“…Ambient and household air pollution is a major health problem worldwide, contributing annually to approximately seven million of all-cause avoidable deaths,…”
Get full text
Journal Article -
18
Classic thrombophilic gene variants
Published in Thrombosis and haemostasis (2015)“…Thrombophilia is defined as a condition predisposing to the development of venous thromboembolism (VTE) on the basis of a hypercoagulable state. Over the past…”
Get more information
Journal Article -
19
Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
Published in Haematologica (Roma) (01-04-2022)Get full text
Journal Article -
20
The never ending success story of tranexamic acid in acquired bleeding
Published in Haematologica (Roma) (01-05-2020)“…Tranexamic acid (TXA) is an anti-fibrinolytic agent that acts by inhibiting plasminogen activation and fibrinolysis. Although its first clinical use dates back…”
Get full text
Journal Article